Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin†
Year: 2009
Type: article
Source: Hepatology
DOI: 10.1002/hep.23444
Institutions: Inserm, Université Paris Diderot, Hôpital Beaujon
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2044547797
